跳至主要内容
临床试验/CTRI/2025/08/092387
CTRI/2025/08/092387招募中2 期

Hypo fractionated radiotherapy in carcinoma cervix- A phase II study.

Post Graduate Institute of Medical Education and Research1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
assess response and acute toxicities, if any

研究概览

简要总结

Hypofractionated radiotherapy (HFRT) is a treatment approach that shortens the overall duration of a radiotherapy treatment course by delivering fewer treatments but with a higher dose of radiation per daily treatment.The benefits of adopting hypofractionated radiotherapy regimens in low middle income countries (LMICs) has been less sought in the literature. Although feasibility studies in this regard are now being done in western countries, prospective studies in Indian setup are lacking.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
Female

入选标准

  • Biopsy proven cancer cervix.
  • Clinical Stage upto IIB with or without radiological IIIC1 KPS more than
  • Willing for participate.

排除标准

  • Post op patients.
  • Pregnant or lactating women.
  • Metastasis.

结局指标

主要结局

assess response and acute toxicities, if any

时间窗: assess response at 3 months and acute toxicities during Radiation therapy and uptil 6 months on 3 monthly follow up.

次要结局

  • late toxicities, quality of life (QOL), Progression free survival (PFS) and overall survival (OS)(at 6 months and 1 year.)

研究者

发起方
Post Graduate Institute of Medical Education and Research
申办方类型
Other [nonfunded]
责任方
Principal Investigator
主要研究者

Divyesh Kumar

Post Graduate Institute of Medical Education and Research

研究点 (1)

Loading locations...

相似试验